Unedited news and product information from vendors.
Education, Reimbursement Options are Key Components of Effective Pharmaceutical Brand Websites
Jul 06, 2012 (10:07 AM EDT)
CHAPEL HILL, N.C., July 6, 2012 /PRNewswire/ -- Chronic conditions such as rheumatoid arthritis and osteoporosis are complex and expensive to treat. But tech-savvy patients take solace in trusted chronic care product websites that help them understand their condition and treatment options better. The need to engage patients in critical information exchange has made it vital for chronic care product websites to effectively present information.
For pharmaceutical companies - especially those with treatments for chronic conditions - it is essential to have brand websites that meet three key objectives:
To show how web-based patient service tools on brand sites can more effectively deliver these three key objectives, Best Practices, LLC conducted a research study to showcase effective online tools for informing patients about their condition, reimbursement options and ongoing treatment support.
The report, "Online Patient Support Excellence: Using Brand Website Services for Condition and Treatment Education," probes 10 chronic care product websites through 51 support categories that appear across the patient lifecycle, from getting started with a product to becoming a loyal patient who adheres to treatment.
This 119-page benchmark study examines 10 leading biopharmaceutical products that treat chronic conditions, such as rheumatoid arthritis, osteoporosis and cancer, for which treatment is often expensive and patient education and long-term support are essential. Benchmark products examined include: Boniva, Cimzia, Enbrel, Forteo, Fosamax, Humira, Reclast, Remicade, Rituxan, and Simponi.
To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1161.htm.
ABOUT BEST PRACTICES, LLC
SOURCE Best Practices, LLC